The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 09, 2015
Filed:
Jul. 09, 2010
Bhujanga Rao Abidhatla Kali Satya, Hyderabad, IN;
Ramanadham Jyothi Prasad, Hyderabad, IN;
Bollepalli Nageshwara Rao, Hyderabad, IN;
Nannapaneni Venkaiah Chowdary, Hyderabad, IN;
Bhujanga rao Abidhatla Kali Satya, Hyderabad, IN;
Ramanadham Jyothi Prasad, Hyderabad, IN;
Bollepalli Nageshwara Rao, Hyderabad, IN;
Nannapaneni Venkaiah Chowdary, Hyderabad, IN;
NATCO PHARMA LIMITED, Hyderabad, Andhra Pradesh, IN;
Abstract
Methods employing and uses of a compound of formula (I) in inhibiting the growth of a tumor cell in a subject in need thereof. Methods employing and uses of a compound of formula (I) in treating pancreatic cancer in a subject in need of treatment for pancreatic cancer. Methods employing and uses of a compound of formula (I) in treating HER-2 positive breast cancer in a subject in need of treatment for HER-2 positive breast cancer. Methods employing and uses of a compound of formula (I) in treating drug resistant non-small cell lung cancer in a subject in need of treatment for drug resistant non-small cell lung cancer. Each of these methods can include administering to the subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof. Method of manufacturing a medicament including a compound of formula (I) for treating a subject suffering from growth of a tumor cell; for treating a subject suffering from pancreatic cancer; for treating a subject suffering from HER-2 positive breast cancer; or for treating a subject suffering from drug resistant non-small cell lung cancer.